Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

27.87USD
17 Aug 2018
Change (% chg)

$-0.13 (-0.46%)
Prev Close
$28.00
Open
$28.12
Day's High
$28.25
Day's Low
$27.23
Volume
152,323
Avg. Vol
273,337
52-wk High
$35.99
52-wk Low
$15.09

Chart for

About

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that... (more)

Overall

Beta: --
Market Cap(Mil.): $1,116.97
Shares Outstanding(Mil.): 36.11
Dividend: --
Yield (%): --

Financials

  NTLA.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.33 -- --
ROI: -17.54 1.78 14.61
ROE: -22.51 3.28 16.33

BRIEF-Intellia Therapeutics Inc Q1 Loss Per Share $0.51

* INTELLIA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

01 May 2018

BRIEF-Intellia Therapeutics Reports Qtrly Net Loss Per Share $0.61

* INTELLIA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

14 Mar 2018

Earnings vs. Estimates